Stroke Clinical Trials

Find Stroke Clinical Trials Near You

TRUST Registry - Targeting Real World Usage In Stroke Treatment A WallabyPhenox Hemorrhagic Stroke Registry

Status: Recruiting
Location: See all (13) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY

TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices. The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Subject treated or intended to be treated with at least one target registry device during the procedure (i.e., at least one attempt of introduction into the vasculature of the subject),

• Non-opposition to data collection or informed consent provided by the subject or legal representative as per country-specific legislation.

Locations
Other Locations
France
CHU Brest - Hôpital de La Cavale Blanche
RECRUITING
Brest
Pitié Salpêtrière Hospital
NOT_YET_RECRUITING
Paris
Germany
Helios Klinikum Erfurt
NOT_YET_RECRUITING
Erfurt
Universitätsklinikum Hamburg-Eppendorf
NOT_YET_RECRUITING
Hamburg
University Hospital Heidelberg
NOT_YET_RECRUITING
Heidelberg
LMU Klinikum
NOT_YET_RECRUITING
München
Klinikum Nürnberg
NOT_YET_RECRUITING
Nuremberg
Italy
Cannizzaro Hospital in Catania
NOT_YET_RECRUITING
Catania
ASST Grande Ospedale Metropolitano Niguarda, Milano
NOT_YET_RECRUITING
Milan
Antonio Cardarelli Hospital- Naples
NOT_YET_RECRUITING
Naples
Slovakia
Univerzitná nemocnica L. Pasteura Košice
RECRUITING
Košice
Switzerland
Universitätsspital Basel
NOT_YET_RECRUITING
Basel
Kantonsspital St.Gallen
NOT_YET_RECRUITING
Sankt Gallen
Time Frame
Start Date: 2026-01-29
Estimated Completion Date: 2041-01
Participants
Target number of participants: 5000
Treatments
Treatment of Intracranial Aneurysm
Patients undergoing treatment for intracranial aneurysms (IA) with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals.~The cohort originates from one overarching registry protocol.
Treatment of Vascular Dissection
Patients undergoing treatment for vascular dissection with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals.~The cohort originates from one overarching registry protocol.
Treatment of Vascular Perforation
Patients undergoing treatment for vascular perforation with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals.~The cohort originates from one overarching registry protocol.
Treatment of Neurovascular Abnormalities
Patients undergoing treatment for neurovascular abnormalities with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals.~The cohort originates from one overarching registry protocol.
Treatment of Atherosclerotic Vascular Stenosis of Intracranial Arteries
Patients undergoing treatment for atherosclerotic vascular stenosis of intracranial arteries with market approved device(s) from WallabyPhenox implantable devices portfolio as per standard of care of participating hospitals. The cohort originates from one overarching registry protocol.
Related Therapeutic Areas
Sponsors
Leads: Phenox GmbH

This content was sourced from clinicaltrials.gov

Similar Clinical Trials